Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (444)

« Back to Publications

Emergency Department Opt‐Out Testing for Hepatitis B: A Two‐Year UK Multicentre Evaluation of Outcomes Across Seven Sites

Plunkett JJ. et al, (2026), Liver International, 46

What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol

Martyn E. et al, (2026), Wellcome Open Research, 11, 285 - 285

Diagnosing and defining MASLD in people living with chronic hepatitis B

Martyn E. et al, (2026), Communications Medicine, 6

Towards the endgame: achieving elimination of viral hepatitis in England

Mandal S. et al, (2026), The Lancet Microbe, 7, 101332 - 101332

Voices from the frontline: how global funding cuts are reshaping the viral hepatitis response

Delphin M. et al, (2026), The Lancet Gastroenterology & Hepatology, 11, 269 - 271

‘EVOLVE-HBV’: A retrospective cross-sectional study to quantify and characterise HBV infection, exposure, immunity and susceptibility in a rural population in KwaZulu-Natal, South Africa

Anderson M. et al, (2026)

Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts

Batbold E. et al, (2026), Nature Reviews Gastroenterology & Hepatology

HepB-boost: Implementation of free-of-charge health care worker hepatitis B testing and vaccination at Kilifi County Referral Hospital, Kenya

Downs LO. et al, (2026), International Journal of Infectious Diseases, 164, 108418 - 108418

Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review

Sukali G. et al, (2026)

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: Long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention

Mugisha J. et al, (2026), Journal of Clinical Virology, 182, 105911 - 105911

Response to Comments on ‘Hepatitis B Virus ( HBV ) Treatment Eligibility in the UK : Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines’

Campbell C. et al, (2026), Journal of Viral Hepatitis, 33

Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort

Lumley SF. et al, (2026), Journal of Infection, 92, 106682 - 106682

Viral hepatitis and liver disease in the Mongolian community in London ('MoLo'): A mixed methods study protocol to investigate the epidemiology and burden of disease to inform clinical and public health interventions

Martyn E. et al, (2026), Wellcome Open Research, 11, 72 - 72

The cumulative incidence and infection hospitalization risk of SARS-CoV-2 by variant: a longitudinal study in England

Gaughan C. et al, (2026), American Journal of Epidemiology, 195, 188 - 197

The effects of multimedia education tools on patients' health knowledge

Jack K. et al, (2026), British Journal of Community Nursing, 31, 28 - 38

Load More

1
2
3
4
5
6
7
...
»